🔥 Friday 21 August 2026 Fri, 21 Aug 2026

Peter Warren Automotive reported a modest revenue increase to AUD 2.489 billion in FY26 but saw profit after tax nearly halve to AUD 6.3 million, reflecting margin pressure in new vehicles and rising operating costs. The company declared a fully franked final dividend of 0.6 cents per share and is poised for growth with expanded Chinese brand exposure and a disciplined acquisition pipeline.

BSP Financial Group has reported an 8.4% increase in net profit to K620 million for the first half of 2026, driven by a 17.7% surge in revenue and supported by a strong capital position and strategic investments.

Guzman y Gomez (ASX: GYG) reported strong FY26 growth with network sales rising 18% and underlying NPAT up 30%, while completing its exit from the US market and announcing a 48 cents fully franked dividend.

James Hardie Industries has agreed to divest its European Fermacell sustainable walling and flooring business to Holcim for €840 million, while planning to close its European fiber cement operations and launch a $250 million share buyback.

Ramelius Resources delivered 192,182 ounces of gold in FY26, meeting guidance for the sixth year, while integrating the Spartan acquisition and advancing key projects including the Rebecca-Roe DFS and Mt Magnet plant upgrade.

Regis Resources (ASX:RRL) delivered a landmark FY26 with a 181% surge in net profit to $715 million, underpinned by strong gold production and record prices. The company declared a fully franked 35 cents per share dividend, including a special 5 cents payout from the terminated Vault Minerals merger break fee.

TradeWindow is positioning itself for a primary ASX listing, appointing two seasoned Australian logistics experts to its board and reshaping its executive team to deepen market expertise and meet listing requirements.

Fisher & Paykel Healthcare has raised its full-year net profit guidance for FY2027, buoyed by robust first-half sales and a $23 million US tariff refund. The medical devices maker forecasts up to 24% profit growth in H1, driven by hospital product demand and operational efficiencies.